Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.715 USD | +7.42% | +1.50% | -43.29% |
05-09 | Barclays Adjusts Editas Medicine Price Target to $9 From $11, Maintains Equal Weight Rating | MT |
05-09 | Morgan Stanley Upgrades Editas Medicine to Equal-Weight From Underweight | MT |
- Stock Market
- Equities
- EDIT Stock
- News Editas Medicine, Inc.
- MarketScreener Strategies